Fierce Healthcare

JANUARY 31, 2022

Cigna taps new exec to lead its US Government Business. Mon, 01/31/2022 - 10:56.

75

75

Fierce Pharma

SEPTEMBER 29, 2023

commercial business. Teva CEO Richard Francis has continued his transformation of the company, bringing on Christine Fox as the new head of its U.S.

89

89

Fierce Healthcare

AUGUST 9, 2023

Beleaguered digital health company Babylon Health shuttered its Austin, Texas, headquarters and laid off 94 employees as it struggled to secure more financing to continue operations.

98

98

PharmExec

APRIL 10, 2024

Decree comes amid the FDA’s 2021 inspection of Philips’ Murrysville facility and the subsequent voluntary recall of its sleep and respiratory care devices.

FDA 52

FDA 52

Fierce Healthcare

FEBRUARY 14, 2024

As clinicians, it's critical for us to be open and accountable for adopting technologies and processes that can help us better serve our patients while meeting the needs of the business. Would-be policy reformers on both the left and right always seem to want major overhauls of the American healthcare system. |

112

112

pharmaphorum

APRIL 23, 2024

BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third quarter of 2025.

71

71

PharmExec

AUGUST 5, 2022

Court Horncastle discusses how his career led him to work with treating COPD and asthma.

111

111

pharmaphorum

MARCH 7, 2024

Boundless Bio made a play to become the seventh US biotech to seek a public listing in 2024, ending a brief hiatus in IPO activity after a busy start to the year.

83

83

STAT

MARCH 14, 2024

Rise and shine, everyone, another busy day is on the way. Please do join us. government scrutiny of the biotech and other Chinese companies , STAT tells us. … The Biotechnology Innovation Organization, the industry trade group, is cutting ties with China’s WuXi in response to increasing U.S.

93

93

Outsourcing Pharma

JANUARY 10, 2024

Informatics software developer supporting R&D, ACD/Labs, has formed a collaboration with MilliporeSigma, the US and Canada Life Science business of Merck KGaA.

104

104

STAT

FEBRUARY 14, 2024

We are doing just fine, thank you, especially since the middle of the week is upon us. And what better way to make the time fly than to keep busy. Food and Drug Administration fully approved a Biogen treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide , The Boston Globe tell us.

86

86

Digital Pharmacist

APRIL 30, 2024

estimated to be spent by US consumers on Mother’s Day Moms Currently in the US % of US adults expected to celebrate Mother’s Day Mother’s Day Ideas for Your Pharmacy As the third-largest retail holiday in the US, Mother’s Day is a great marketing opportunity.

Communication 97

Communication 97

STAT

APRIL 25, 2024

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by is picking up, and the official mascots are busy foraging for snacks on the official grounds. As for us, we are engaged in the usual ritual of brewing cups of stimulation.

Packaging 84

Packaging 84

STAT

APRIL 18, 2024

Rise and shine, everyone, another busy day is on the way. We recall a bit of insight from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.” biotechs from doing business with the Chinese behemoth , STAT says. Our choice today is pistachio creme.

90

90

STAT

OCTOBER 30, 2023

President Joe Biden ordered the nation’s leading health agencies on Monday to develop a plan for regulating artificial intelligence tools already widely in use within hospitals, insurance companies, and other health-related businesses.

Insurance 120

Insurance Hospitals 120

Pharmacy Is Right For Me

JANUARY 25, 2023

I worked most of my career in the biopharmaceutical industry in various commercial roles, such as sales, marketing account management, strategic consulting, and business development. Three years ago, I returned to the US to start IndyCare with a pharmacy school friend of mine, Greg Vassie. It’s pretty intense.

Community Pharmacies 130

Community Pharmacies Insurance Patient Care 130

STAT

JANUARY 30, 2024

As for us, we are as busy as ever hunting and gathering items of interest. We trust you have your own busy agendas. So join us as we hoist the ever-present cup of stimulation — our choice today is cinnamon sticky bun — and attack the fast-growing to-do list.

Pharmaceutical Companies 84

Pharmaceutical Companies Pharmaceutical Companies 84

STAT

APRIL 9, 2024

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by is picking up, and the official mascots are busy foraging for snacks on the official grounds. As for us, we are engaged in the usual ritual of brewing cups of stimulation.

Vaccines 65

Vaccines 65

PharmExec

DECEMBER 8, 2022

Kimberly Moran, head of rare diseases in the US for UCB, started off working in medicine but quickly learned the importance of the business side of industry—and its role in helping improve the diagnosis and access paths for underserved patient segments.

105

105

STAT

DECEMBER 19, 2023

As for us, we are as busy as ever hunting and gathering items of interest. We trust you have your own busy agendas. So join us as we hoist the ever-present cup of stimulation — our choice today is gingerbread — and attack the fast-growing to-do list.

96

96

STAT

MAY 2, 2024

Rise and shine, everyone, another busy day is on the way. We recall a bit of insight from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.” Sadly, gray skies are hovering over the Pharmalot campus again, but our spirits remain sunny, nonetheless.

Insurance 72

Insurance 72

STAT

AUGUST 28, 2023

But if you’re working in a clinic setting (like one of us, Jessi, is currently, and the other, Simone, has done previously), one thing is for sure: You’re busy. When you’re a psychiatrist, there’s no such thing as a typical day. Read the rest…

89

89

STAT

SEPTEMBER 22, 2023

Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Previously, he worked at Nkarta, where he was chief financial and business officer. Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?

86

86

European Pharmaceutical Review

APRIL 15, 2024

billion to expand the planned FUJIFILM Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina, US. The expansion means identical large-scale production facilities can be built in US and Europe to support integration drug manufacturing production “regardless of location”, FUJIFILM explained.

84

84

Pharmaceutical Technology

NOVEMBER 2, 2022

Reduction in revenues from Comirnaty outside the US and reduced revenues for some Comirnaty-linked manufacturing works carried out on behalf of BioNTech, Xeljanz and Sutent worldwide were the key drivers that contributed to the revenue decline in Q3 2022. in the third quarter last year, indicating a 6% growth. in the prior-year quarter.

116

116

The FDA Law Blog

JANUARY 11, 2024

This day-long (FREE) seminar is a must-attend event for anyone in the pharmaceutical sector interested in understanding the “ins and outs” of doing business in the Territory, as well as an opportunity to interact with those who already have a keen understanding of doing business in Puerto Rico. HPM is a co-sponsor of the event.

Controlled Substances 59

Controlled Substances 59

STAT

NOVEMBER 30, 2023

Rise and shine, everyone, another busy day is on the way. As for us, we are dutifully firing up the coffee kettle to brew another cup of needed stimulation. Please feel free to join us. We hope you find these useful and have a smashing day. Our choice today is blueberry cobbler. Our choice today is blueberry cobbler.

Compounding 93

Compounding Compounding Pharmacies Chemotherapy FDA 93

The Guardian - Pharmaceutical Industry

FEBRUARY 22, 2024

Mark Crossley, the Indivior chief executive, said: “We are excited to announce that we are initiating consultations with shareholders on potentially transitioning to a primary listing in the US in 2024 while maintaining a secondary listing in the UK.” Continue reading.

52

52

STAT

APRIL 10, 2024

We are doing just fine, thank you, especially since the middle of the week is upon us. And what better way to make the time fly than to keep busy. Now, though, the time has come to get busy. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not?

82

82

STAT

MARCH 1, 2024

Share the news with us, and we’ll share it with others. That’s  Send us your changes, and we’ll find a home for them. Previously, she worked at Kira Pharma, where she was head of business development and strategy. Hired someone new and exciting? Promoted a rising star? Don’t be shy.

76

76

European Pharmaceutical Review

FEBRUARY 5, 2024

Incentivising small molecule drug innovation According to the Biotechnology Innovation Organization (BIO), the bipartisan Ensuring Pathways to Innovative Cures ( EPIC Act ) passed last week in the US, is a “critical” step for incentivising small molecule drug innovation.

FDA 78

FDA 78

STAT

FEBRUARY 7, 2024

The middle of the week is upon us. And what better way to make the time fly than to keep busy. Meanwhile, do keep us in mind if you hear anything interesting. Rise and shine, everyone. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? Consider the alternatives, if you must.

Insurance 96

Insurance 96

STAT

SEPTEMBER 7, 2023

Josh Schimmer and Eric Schmidt, two longtime analysts teaming up at Cantor Fitzgerald, join us for a back-to-school conversation as biotech enters the busy back third of 2023. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

88

88

Outsourcing Pharma

AUGUST 11, 2021

The US Food and Drug Administration has kept its staff busy with approvals, authorizations, and warnings related to various coronavirus-centered products.

FDA 98

FDA 98

STAT

MARCH 19, 2024

Rise and shine, everyone, another busy day is on the way. As for us, we are engaged in the usual rituals, starting with brewing cups of stimulation. Please feel free to join us. Already, the official mascots are racing about the Pharmalot campus in search of breakfast and a steady stream of traffic can be heard nearby.

97

97

STAT

JUNE 27, 2023

The protesters were crammed into an already busy part of the city. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

Insurance 118

Insurance 118

STAT

AUGUST 7, 2023

NEW YORK — A nurse supervisor at Montefiore Comprehensive Health Care Center in the Bronx was delivering her start-of-shift updates and mantras — “Covid is not finished with us … clean, clean, clean!”— ”— to the clinicians and administrative staff bunched up nearby.

Hospitals 97

Hospitals 97